Skip to main content

Peer Review reports

From: Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

Original Submission
26 Nov 2018 Submitted Original manuscript
13 Feb 2019 Author responded Author comments - Paul Lesueur
Resubmission - Version 2
13 Feb 2019 Submitted Manuscript version 2
21 Feb 2019 Author responded Author comments - Paul Lesueur
Resubmission - Version 3
21 Feb 2019 Submitted Manuscript version 3
Publishing
27 Feb 2019 Editorially accepted
4 Mar 2019 Article published 10.1186/s12885-019-5413-y

You can find further information about peer review here.

Back to article page